The U.S. Compression Therapy Market was valued at USD 1.58 Billion in 2024, and is projected to reach USD 1.87 Billion by 2030, rising at a CAGR of 2.82%. Rising rates of chronic venous disorders, such as chronic venous insufficiency (CVI) and deep vein thrombosis (DVT), drive demand for compression therapy. Compression therapy helps manage these conditions by improving blood circulation and reducing swelling.
According to the National Center for Biotechnology Information 2022, DVT affects more than 200,000 people in the U.S. Increased awareness about the benefits of compression therapy through educational campaigns and health promotion initiatives drives consumer demand. Understanding how compression therapy can alleviate symptoms and improve quality of life encourages adoption. The growing emphasis on preventive health and self-care encourages the use of compression therapy as a proactive measure to prevent or manage chronic conditions.
The shift towards home healthcare and outpatient care increases the demand for compression therapy products that can be used outside of clinical settings. This trend includes the use of compression garments and devices at home for ongoing condition management. Home healthcare services and online purchasing options make compression therapy products more accessible to patients. Improved reimbursement policies and insurance coverage for compression therapy products help reduce financial barriers for patients and healthcare providers, which facilitates the adoption of these products.
The pandemic led to increased awareness of the importance of medical supplies, including compression therapy products. Patients recovering from severe cases of COVID-19, especially those with extended hospital stays or who experienced complications such as deep vein thrombosis (DVT), have heightened demand for compression therapy. The pandemic caused significant disruptions in global supply chains, affecting the production and distribution of compression therapy products. Lockdowns, factory closures, and shipping delays impacted the availability of raw materials and finished goods. The pandemic accelerated research and development efforts in the healthcare sector, including the development of new compression therapy solutions that address both COVID-19-related complications and other health conditions.
The compression therapy market is subject to stringent regulatory requirements set by organizations such as the Food and Drug Administration. Ensuring compliance with these regulations can be challenging and costly for manufacturers. Advanced compression therapy products, such as those with smart technology or custom fittings, can be expensive. High costs may limit accessibility for some patients and healthcare facilities. Insurance coverage and reimbursement policies for compression therapy products can be inconsistent and vary widely among insurers. This variability can create financial burdens for patients and affect market growth. The quality and effectiveness of compression therapy products available in the market vary. Manufacturers face a challenge in ensuring that all products meet high standards for performance and safety.
This product will be delivered within 1-3 business days.
According to the National Center for Biotechnology Information 2022, DVT affects more than 200,000 people in the U.S. Increased awareness about the benefits of compression therapy through educational campaigns and health promotion initiatives drives consumer demand. Understanding how compression therapy can alleviate symptoms and improve quality of life encourages adoption. The growing emphasis on preventive health and self-care encourages the use of compression therapy as a proactive measure to prevent or manage chronic conditions.
The shift towards home healthcare and outpatient care increases the demand for compression therapy products that can be used outside of clinical settings. This trend includes the use of compression garments and devices at home for ongoing condition management. Home healthcare services and online purchasing options make compression therapy products more accessible to patients. Improved reimbursement policies and insurance coverage for compression therapy products help reduce financial barriers for patients and healthcare providers, which facilitates the adoption of these products.
The pandemic led to increased awareness of the importance of medical supplies, including compression therapy products. Patients recovering from severe cases of COVID-19, especially those with extended hospital stays or who experienced complications such as deep vein thrombosis (DVT), have heightened demand for compression therapy. The pandemic caused significant disruptions in global supply chains, affecting the production and distribution of compression therapy products. Lockdowns, factory closures, and shipping delays impacted the availability of raw materials and finished goods. The pandemic accelerated research and development efforts in the healthcare sector, including the development of new compression therapy solutions that address both COVID-19-related complications and other health conditions.
The compression therapy market is subject to stringent regulatory requirements set by organizations such as the Food and Drug Administration. Ensuring compliance with these regulations can be challenging and costly for manufacturers. Advanced compression therapy products, such as those with smart technology or custom fittings, can be expensive. High costs may limit accessibility for some patients and healthcare facilities. Insurance coverage and reimbursement policies for compression therapy products can be inconsistent and vary widely among insurers. This variability can create financial burdens for patients and affect market growth. The quality and effectiveness of compression therapy products available in the market vary. Manufacturers face a challenge in ensuring that all products meet high standards for performance and safety.
U.S. Compression Therapy Market Report Highlights
- Static compression therapy dominated the technology segment in 2024 due to the broad range of products, such as compression stockings, sleeves, and bandages.
- This variety caters to different patient needs and conditions, contributing to its market dominance.
- On the other hand, the dynamic compression therapy segment is expected to grow at the fastest CAGR.
- Based on end-use, hospitals segment dominated the market with a share of 31.14% in 2024.
- In 2024, the institutional sales segment dominated the market in 2024. Due to their high patient volume, institutions such as hospitals and large clinics procure compression therapy products in bulk, which drives significant sales through institutional channels.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Compression Therapy Market Variables, Trends & Scope
Chapter 4. U.S. Compression Therapy Market: Technology Estimates & Trend Analysis
Chapter 5. U.S. Compression Therapy Market: End Use Estimates & Trend Analysis
Chapter 6. U.S. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this U.S. Compression Therapy market report include:- Cardinal Health
- 3M
- SIGVARIS GROUP
- Essity
- Julius Zorn, Inc.
- HARTMANN USA, Inc
- Bauerfeind USA Inc.
- medi USA
- BIOCOMPRESSION SYSTEMS
- Gottfried Medical, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.58 Billion |
| Forecasted Market Value ( USD | $ 1.87 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | United States |
| No. of Companies Mentioned | 11 |
